Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 22, 1999

View Archived Issues

Privately Held CeNeS Proposes Reverse Merger With Core Group

U.S. Official Blasts EU Leaders On Their Approach To Biotech

Arcoda Plans To Use Financing To Invest In Start-Up Companies

Retraining Might Be Necessary To Supplement Cell Transplants

EuropaBio Decries Report On Control Of GM Seeds Industry

Companies Flock To Ginoptle, The 'Genetics Valley' of France

German Agency Founded To Focus Solely On Biotechnology

German Consortium Started To Link Genomics Information

Australian Researchers Plan Late-Stage Study For Warts

French Corn Producers Say Biotech Needed To Compete

XTL's Animal Model For HCV Licensed For Testing By Lilly

Evotec Cancels Initial Offering Due To Conditions In Germany

Vanguard Sings On Distributor In Europe For Migraine Drug

Transghne Starts First Study Of MVA-HPV Cancer Vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...